midazolam has been researched along with Hearing Loss in 2 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tinnitus is a phantom auditory perception, which can be induced via application of concentrated sodium salicylate, and is known to be associated with hearing loss and altered neuronal excitability in peripheral and central auditory neurons." | 5.35 | Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity. ( Geisler, HS; Hadjab, S; Knipper, M; Köpschall, I; Oestreicher, E; Panford-Walsh, R; Rohbock, K; Rüttiger, L; Singer, W; Tan, J; Vieljans, A; Zimmermann, U, 2008) |
| "Tinnitus is a phantom auditory perception, which can be induced via application of concentrated sodium salicylate, and is known to be associated with hearing loss and altered neuronal excitability in peripheral and central auditory neurons." | 1.35 | Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity. ( Geisler, HS; Hadjab, S; Knipper, M; Köpschall, I; Oestreicher, E; Panford-Walsh, R; Rohbock, K; Rüttiger, L; Singer, W; Tan, J; Vieljans, A; Zimmermann, U, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tye-Murray, N | 1 |
| Spehar, B | 1 |
| Mauze, E | 1 |
| Cardinal, C | 1 |
| Panford-Walsh, R | 1 |
| Singer, W | 1 |
| Rüttiger, L | 1 |
| Hadjab, S | 1 |
| Tan, J | 1 |
| Geisler, HS | 1 |
| Zimmermann, U | 1 |
| Köpschall, I | 1 |
| Rohbock, K | 1 |
| Vieljans, A | 1 |
| Oestreicher, E | 1 |
| Knipper, M | 1 |
2 other studies available for midazolam and Hearing Loss
| Article | Year |
|---|---|
Hearing Health Care Digital Therapeutics: Patient Satisfaction Evidence.
Topics: Aged; Hearing; Hearing Aids; Hearing Loss; Humans; Midazolam; Patient Satisfaction | 2022 |
Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity.
Topics: Animals; Auditory Cortex; Auditory Pathways; Auditory Perception; Behavior, Animal; Brain-Derived Ne | 2008 |